Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
PLoS Negl Trop Dis. 2021 Feb 3;15(2):e0009129. doi: 10.1371/journal.pntd.0009129. eCollection 2021 Feb.
Effective case identification strategies are fundamental to capturing the remaining visceral leishmaniasis (VL) cases in India. To inform government strategies to reach and sustain elimination benchmarks, this study presents costs of active- and passive- case detection (ACD and PCD) strategies used in India's most VL-endemic state, Bihar, with a focus on programme outcomes stratified by district-level incidence.
Expenditure analysis was complemented by onsite micro-costing to compare the cost of PCD in hospitals alongside index case-based ACD and a combination of blanket (house-to-house) and camp ACD from January to December 2018. From the provider's perspective, a cost analysis evaluated the overall programme cost of each activity, the cost per case detected, and the cost of scaling up ACD.
During 2018, index case-based ACD, blanket and camp ACD, and PCD reported 1,497, 131, and 1,983 VL-positive cases at a unit cost of $522.81, $4,186.81, and $246.79, respectively. In high endemic districts, more VL cases were identified through PCD while in meso- and low-endemic districts more cases were identified through ACD. The cost of scaling up ACD to identify 3,000 additional cases ranged from $1.6-4 million, depending on the extent to which blanket and camp ACD was relied upon.
Cost per VL test conducted (rather than VL-positive case identified) may be a better metric estimating unit costs to scale up ACD in Bihar. As more VL cases were identified in meso-and low-endemic districts through ACD than PCD, health authorities in India should consider bolstering ACD in these areas. Blanket and camp ACD identified fewer cases at a higher unit cost than index case-based ACD. However, the value of detecting additional VL cases early outweighs long-term costs for reaching and sustaining VL elimination benchmarks in India.
有效的病例识别策略是印度捕捉剩余内脏利什曼病(VL)病例的基础。为了为政府提供制定达到并维持消除基准的策略信息,本研究报告了在印度最易感染内脏利什曼病的邦比哈尔邦使用的主动和被动病例检测(ACD 和 PCD)策略的成本,重点是按地区发病率分层的方案结果。
支出分析辅以现场微观成本分析,以比较 2018 年 1 月至 12 月期间医院内的 PCD 成本,以及基于索引病例的 ACD 和全面(挨家挨户)和营地 ACD 的成本。从提供者的角度来看,成本分析评估了每个活动的总计划成本、每例病例的检测成本以及 ACD 扩大规模的成本。
在 2018 年,基于索引病例的 ACD、全面和营地 ACD 以及 PCD 分别报告了 1497、131 和 1983 例 VL 阳性病例,单位成本分别为 522.81 美元、4186.81 美元和 246.79 美元。在高流行地区,通过 PCD 发现了更多的 VL 病例,而在中低流行地区,通过 ACD 发现了更多的病例。扩大 ACD 以发现 3000 例额外病例的成本范围为 160 万至 400 万美元,具体取决于对全面和营地 ACD 的依赖程度。
每进行一次 VL 检测的成本(而不是发现的 VL 阳性病例数)可能是估计在比哈尔邦扩大 ACD 规模的单位成本的更好指标。由于通过 ACD 在中低流行地区发现的 VL 病例多于 PCD,印度卫生当局应考虑在这些地区加强 ACD。全面和营地 ACD 发现的病例较少,但单位成本较高,而基于索引病例的 ACD 发现的病例较少。然而,早期发现更多 VL 病例的价值超过了印度达到和维持 VL 消除基准的长期成本。